Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Yuan Zeng

Hubei Cancer Hospital

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · JOURNAL ARTICLE

Combination of PD-1 inhibitor and chemotherapy for subcutaneous soft-tissue metastasis in postoperative non-small cell lung cancer

Medicine

A single case report with no comparator, control group, or quantified efficacy metrics; describes feasibility and tolerability rather than establishing efficacy through controlled evidence.

PreliminaryYuan Zeng Yang Hu Qiang Zeng

Study details

Participantsn = 1

DesignSingle-case report

InterventionPlatinum-based doublet chemotherapy combine…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support